You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華蘭生物(002007.SZ):取得三種規格的靜注人免疫球蛋白臨牀試驗通知書
格隆匯 04-22 17:40

格隆匯4月22日丨華蘭生物(002007.SZ)公佈,公司於近日取得了國家藥品監督管理局簽發的三種規格的靜注人免疫球蛋白《臨牀試驗通知書》,上述產品是採用層析純化工藝和納米膜過濾+pH孵放雙重去除病毒工藝製備而成的新一代靜注人免疫球蛋白,在質量標準、產品收率、病毒安全性等方面均得到了提高,目前國內尚無同類技術及高濃度產品上市。述產品的具體信息如下:

按照藥品註冊程序,公司在取得三種規格的靜注人免疫球蛋白《臨牀試驗通知書》後,將按照國家藥品臨牀試驗的要求儘快開展臨牀試驗,待臨牀試驗成功後將申報產品生產批件。上述臨牀試驗的完成時間、進度及結果均具有一定的不確定性。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account